Colfax (NYSE:CFX)‘s stock had its “buy” rating restated by equities research analysts at Stifel Nicolaus in a research report issued to clients and investors on Tuesday, Marketbeat.com reports. They presently have a $48.00 price objective on the industrial products company’s stock, up from their previous price objective of $44.00. Stifel Nicolaus’ target price points to a potential upside of 14.94% from the company’s current price.

A number of other analysts also recently issued reports on the stock. Royal Bank of Canada restated a “buy” rating and set a $44.00 price target on shares of Colfax in a report on Tuesday, November 7th. Zacks Investment Research downgraded shares of Colfax from a “buy” rating to a “hold” rating in a report on Tuesday, October 17th. Robert W. Baird restated a “buy” rating and set a $50.00 price target on shares of Colfax in a report on Friday, October 27th. Cowen downgraded shares of Colfax from an “outperform” rating to a “market perform” rating in a report on Wednesday, October 18th. Finally, Longbow Research raised shares of Colfax from a “neutral” rating to a “buy” rating in a research report on Tuesday, November 21st. Two equities research analysts have rated the stock with a sell rating, five have given a hold rating, eight have given a buy rating and one has issued a strong buy rating to the company’s stock. Colfax presently has an average rating of “Buy” and an average target price of $46.20.

Shares of Colfax (NYSE CFX) traded up $0.35 during midday trading on Tuesday, hitting $41.76. 375,300 shares of the stock were exchanged, compared to its average volume of 602,433. The firm has a market cap of $5,141.31, a P/E ratio of 29.41, a P/E/G ratio of 1.60 and a beta of 1.27. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.80 and a quick ratio of 1.47. Colfax has a fifty-two week low of $33.31 and a fifty-two week high of $43.29.

Colfax (NYSE:CFX) last announced its quarterly earnings results on Monday, November 6th. The industrial products company reported $0.42 earnings per share (EPS) for the quarter, hitting the Zacks’ consensus estimate of $0.42. The business had revenue of $844.50 million during the quarter, compared to the consensus estimate of $901.09 million. Colfax had a net margin of 4.89% and a return on equity of 6.26%. The business’s revenue was up 10.2% compared to the same quarter last year. During the same quarter last year, the firm earned $0.39 EPS. equities research analysts forecast that Colfax will post 1.72 earnings per share for the current fiscal year.

In related news, EVP Daniel A. Pryor sold 53,333 shares of the stock in a transaction that occurred on Tuesday, December 19th. The shares were sold at an average price of $38.15, for a total transaction of $2,034,653.95. Following the completion of the transaction, the executive vice president now owns 93,557 shares of the company’s stock, valued at approximately $3,569,199.55. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 10.60% of the company’s stock.

Hedge funds have recently modified their holdings of the business. Toronto Dominion Bank purchased a new position in Colfax in the 2nd quarter valued at approximately $118,000. Zurcher Kantonalbank Zurich Cantonalbank boosted its position in Colfax by 10.1% in the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,533 shares of the industrial products company’s stock valued at $139,000 after buying an additional 323 shares during the period. The Manufacturers Life Insurance Company boosted its position in Colfax by 7.3% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 3,688 shares of the industrial products company’s stock valued at $145,000 after buying an additional 251 shares during the period. FNY Managed Accounts LLC purchased a new position in Colfax in the 3rd quarter valued at approximately $160,000. Finally, Valeo Financial Advisors LLC purchased a new position in Colfax in the 3rd quarter valued at approximately $177,000. 74.89% of the stock is owned by institutional investors.

TRADEMARK VIOLATION WARNING: “Colfax (CFX) Given “Buy” Rating at Stifel Nicolaus” was reported by American Banking News and is the sole property of of American Banking News. If you are viewing this article on another publication, it was illegally stolen and reposted in violation of US and international copyright and trademark law. The legal version of this article can be read at https://www.americanbankingnews.com/2018/01/16/colfax-cfx-price-target-increased-to-48-00-by-analysts-at-stifel-nicolaus.html.

About Colfax

Colfax Corporation is an industrial manufacturing and engineering company. The Company provides air and gas handling, and fabrication technology products and services. The Company’s segments include Air and Gas handling, and Fabrication Technology. The Air and Gas Handling segment supplies a range of gas handling products, including heavy-duty centrifugal and axial fans, rotary heat exchangers, gas compressors, pumps and certain related products, as well as aftermarket services.

Analyst Recommendations for Colfax (NYSE:CFX)

Receive News & Ratings for Colfax Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colfax and related companies with MarketBeat.com's FREE daily email newsletter.